Stanford University

Showing 1,261-1,270 of 2,469 Results

• Amy Lewis

  Senior Grants Manager, Geballe Laboratory for Advanced Materials
  
• 

  Richard Lewis

  Professor of Molecular and Cellular Physiology, Emeritus
  

  Current Research and Scholarly InterestsWe study molecular mechanisms of calcium signaling with a focus on store-operated CRAC channels and their essential roles in T cell development and function. Currently we aim to define the molecular mechanism for CRAC channel activation and the means by which calcium signal dynamics mediate specific activation of transcription factors and T-cell genes during development.
• 

  Ada Li

  Events and Special Projects Coordinator, Sarafan ChEM-H
  
• 

  Fei-Fei Li

  Sequoia Capital Professor, Senior Fellow at HAI and Professor, by courtesy, of Operations, Information and Technology at the Graduate School of Business
  

  Current Research and Scholarly InterestsAI, Machine Learning, Computer Vision, Robotics, AI+Healthcare, Human Vision
• 

  Gordon Li, MD

  Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences and of Otolaryngology - Head & Neck Surgery (OHNS)
  

  Current Research and Scholarly Interests1.) My laboratory studies the biology of brain tumors with the goal of developing novel therapeutics for the treatment of malignant brain tumors and translating that research into clinical trials.
  2.) My clinical interests include improving surgical techniques for brain tumor surgery, immunotherapy for the treatment of glioblastoma, and novel uses for stereotactic radiosurgery.
• Hongbin Li

  Senior Fellow at the Stanford Institute for Economic Policy Research, at the Freeman Spogli Institute for International Studies and Professor, by courtesy, of Economics
  
• 

  Jin Billy Li

  Professor of Genetics
  

  Current Research and Scholarly InterestsThe Li Lab is primarily interested in RNA editing mediated by ADAR enzymes. We co-discovered that the major function of RNA editing is to label endogenous dsRNAs as "self" to avoid being recognized as "non-self" by MDA5, a host innate immune dsRNA sensor, leading us to pursue therapeutic applications in cancer, autoimmune diseases, and viral infection. The other major direction of the lab is to develop technologies to harness endogenous ADAR enzymes for site-specific transcriptome engineering.

  • Contact Info

  • Web page:

    http://lilab.stanford.edu
• Li Li

  Affiliate, Stanford Nano Shared Facilities
  
• 

  Lingyin Li

  Professor of Biochemistry
  

  Current Research and Scholarly InterestsUnderstanding and targeting the cGAS-cGAMP-STING pathway for the treatment of cancer and autoimmunity.
• 

  Minxing Li

  Senior Licensing and Strategic Alliances Manager, Life Sciences, Office of Technology Licensing (OTL)
  

  BioMinxing is a Licensing and Strategic Alliances Manager at Stanford OTL with a focus on life sciences technologies. Since she joined Stanford in 2020, she has been involved in protecting, marketing and licensing of Stanford's intellectual property. She is currently responsible for managing Stanford's alliances with the Parker Institute for Cancer Immunotherapy (PICI), where she works closely with investigators who are part of the PICI network and manages IP and licensing matters under the PICI relationship.
  
  Prior to Stanford, Minxing worked as a consultant at IQVIA, Inc.